Response to a foot muscle strengthening program in a man of ~85 years with intrinsic foot muscle atrophy
Withdrawn
- Conditions
- Gezonde oudere volwasseneMuscle atrophymuscle weakness
- Registration Number
- NL-OMON50361
- Lead Sponsor
- Fontys Hogescholen
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Withdrawn
- Sex
- Not specified
- Target Recruitment
- 1
Inclusion Criteria
A man of around 85 years of age, atrophy of intrinsic foot muscles
Exclusion Criteria
No neurological, neuromuscular or musculoskeletal conditions that is
anticipated to affect gait, balance or to interfere with the execution of the
exercises
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>The change in 1) foot muscles* size measures derived from ultrasound imaging,<br /><br>2) gait biomechanics and spatiotemporal parameters and 3) balance during gait<br /><br>after 12 weeks of intervention.</p><br>
- Secondary Outcome Measures
Name Time Method <p>none</p><br>
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie intrinsic foot muscle atrophy in elderly patients like those in NL-OMON50361?
How does foot muscle strengthening compare to standard physical therapy for muscle weakness in older adults?
Are there specific biomarkers that predict response to foot muscle strengthening in elderly individuals with atrophy?
What adverse events are associated with foot muscle strengthening programs in geriatric populations and how are they managed?
What combination therapies or alternative approaches show promise for treating intrinsic foot muscle atrophy in the elderly?